1. Membrane Transporter/Ion Channel
  2. P-glycoprotein
  3. OY-101

OY-101 是一种口服有效且特异性的 P-glycoprotein (P-gp) 抑制剂。 OY-101可使耐药肿瘤增敏,有效逆转肿瘤多药耐药。与 Tetrandrine (HY-13764) 相比,OY-101 在水溶性、细胞毒性和逆转活性方面有所改善。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

OY-101 Chemical Structure

OY-101 Chemical Structure

CAS No. : 41183-02-2

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of OY-101:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

OY-101 is an orally active, potent and specific P-glycoprotein (P-gp) inhibitor. OY-101 can sensitize drug-resistant tumors and effectively reverse tumor multidrug resistance. OY-101 is improvements in water-solubility, cytotoxicity, and reversal activity compared to Tetrandrine (HY-13764)[1].

体外研究
(In Vitro)

OY-101 与Vincristine (HY-N0488A) 对耐药细胞 Eca109/VCR 表现出优异的协同抗癌作用,IC50 为 9.9 ± 1.3 nM< sup>[1]。
OY-101 (0-5 μM) 对 Eca109/VCR 细胞没有显著毒性,并且在 Eca109/VCR 细胞中表现出显着增加的Vincristine (HY-N0488A) 敏感性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Eca109/VCR cells
Concentration: 1.0, 2.5, and 5.0 μM
Incubation Time: 48 h
Result: Exhibited significantly increased Vincristine sensitization in Eca109/VCR cells, achieving around 3.7, 103.4, and 690.6-fold reversal activity, respectively.
体内研究
(In Vivo)

OY-101 (30 mg/kg/2 天,灌胃,持续 3 周)增加体内对长春新碱 (HY-N0488A) 的致敏性,且无明显毒性[1]
OY-101 (静脉给药 (3 mg/kg) 和口服给药 (30 mg/kg);一次) 表现出良好的药代动力学[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female nude mice (4-5 weeks old, xenograft model bearing P-gp-overexpressing Eca109/VCR cells)[1]
Dosage: 30 mg/kg
Administration: IG, once every 2 days, for 3 weeks, 1 h before tail vein injection of Vincristine (HY-N0488A)
Result: Only co-administration OY-101 with Vincristine can effectively inhibit tumor proliferation in vivo (P < 0.001) and significantly reduce tumor weight. After 3 weeks of treatment, the tumor growth inhibition rate of the OY-101/Vincristine combination was 79.13%, which was significantly lower than that of the single-treatment group and the vehicle group.
Animal Model: SD rats (8 week-old, male, 300-400 g)[1]
Dosage: 3 mg/kg (IV), 30 mg/kg (PO)
Administration: Intravenous and oral administration, once (Pharmacokinetic Analysis)
Result: Pharmacokinetic Parameters of OY-101 in male Sprague-Dawley rats[1].
IV (3 mg/kg) PO (30 mg/kg)
Tmax (h) 0.17 ± 0.12 0.38 ± 0.18
Cmax (ng/mL) 1573.20 ± 143.97 636.55 ± 355.60
AUC0-t (ng/mL∗h) 2688.45 ± 180.10 2665.45 ± 450.92
t1/2 (h) 8.43 ± 7.83 7.37 ± 4.92
CL/F (L/kg/h) 1.10 ± 0.08 11.16 ± 2.10
Vz/F (L/kg) 12.84 ± 11.33 111.27 ± 56.82
F (%) 7.65 ± 2.15
分子量

433.54

Formula

C27H31NO4

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
OY-101
目录号:
HY-149053
需求量: